When used as part of a comprehensive health strategy, microdosing GLP 1 medications can become a tool for metabolic resilience rather than a temporary solution
Treatment typically begins with a low starter dose (0.25 mg weekly for 4 weeks), followed by gradual increases (0.5 mg, then up to 12 mg weekly for Ozempic, or up to 2.4 mg for Wegovy), depending on tolerability and clinical response
Acknowledgements The work was partially supported by the Research Council of Norway through its Centres of Excellence scheme, project number 332727, and grant 274993 (J.T.A., J.N., and S.B.), grant 287927 (J.T.A., K.H.A., and F.R.J.), and grant 285136 (J.T.A.)
For laboratory research use only.
A supplier whose retatrutide is consistently $30-40 CAD below the market average likely isn't testing every batch through Janoshik